Ximedica

Ximedica

Ximedica was founded in 1986 as a product development consultancy with a focus on medical devices. Kevin Grim leads as president and CEO; James Tague serves as COO and David Milne as CFO. The firm's ownership structure is not fully public, though it has been owned by private equity investors including Prospect Partners, which acquired a stake in 2007. Ximedica's core offering spans industrial design, mechanical and electrical engineering, software development, and regulatory affairs — covering nearly every stage of the medtech lifecycle. The firm serves clients across multiple clinical areas: cardiovascular, orthopedics, surgical instruments, and diagnostics. It operates from offices in Providence and Boston, and works with clients in North America and Western Europe. No recent AUM or deployment numbers are disclosed; Ximedica is not a capital allocator but a service provider to the medtech industry. The firm employs an estimated 200 to 300 professionals across its two offices. Its private equity-backed history suggests a focus on organic growth and strategic acquisitions. Ximedica's differentiator is its vertically integrated model combining engineering design, regulatory expertise, and manufacturing guidance under one roof. This bundling reduces time-to-market for medtech clients and differentiates it from pure industrial design shops or contract engineering firms. The firm does not take equity stakes in clients' products.